Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 911-915-8 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Carcinogenicity
Administrative data
Description of key information
Oleaflur, a structure analogue of Olaflur, possessed no carcinogenic potential both in the rat and in the mouse when tested in carcinogenicity studies up to high dose-levels that caused a minimum toxic effects. Consequently, no carcinogenic effects are expected for Olaflur, also taken into account the lack of any mutagen or genotoxic potential in vivo and in vitro.
Key value for chemical safety assessment
Justification for classification or non-classification
The test item did not induce any carcinogenic effects when tested in carcinogenicity studies in the mouse and rat, respectively.
Therefore, it is not subject to classification and labelling for carcinogenicity according to Directive 67/548/EEC (DSD) and Regulation (EC) No. 1272/2008 (CLP). This is in line with results obtained when tested for genetic toxicity in vivo and in vitro.
The available experimental test data are reliable and suitable for classification purposes under Regulation (EC) No 1272/2008. Based on available data on toxicity to reproduction, the test item is not classified according to Regulation (EC) No 1272/2008 (CLP), as amended for the eighth time in Regulation (EU) No 2016/918.
Additional information
Mouse:
In a carcinogenicity study (LTP, 2003), Oleaflur was administered to NMRI CD/Crl:NMRI BR mice (50 animals/sex/dose) by oral gavage at dose levels of 0, 6, 18 or 54 mg/kg bw/day (males) and 0, 6 (12), 18 (36) or 54 (108/72) mg/kg bw/day (females) for 78 weeks. From test week 14 onwards, the dose levels of the female animals were increased, because the body weight reduction of the high-dosed animals was not within the expected range in comparison to the control group. From test week 66 onwards the high dose level of the females was decreased, because of the slightly higher than the expected mortality rate and body weight reduction in this group compared to the control group (Due to the variable dose concentrations given over the test period the mean value of ca. 90 mg/kg bw/d as high-dose level was calculated). The high dose resulted in an average body weight reduction of 8.7 % in the males and 8.6 % in the females compared to the control group. Further, pilo-erection was noted in the high dose. Mortality rates of all dose groups were within the range of the control group. In conclusion, Oleaflur possessed no carcinogenic potential in the mouse tested up to a high dose-level that caused a toxic effect in form of an approx. 9 % weight loss compared to the control. Therefore the NOEL for systemic toxicity was established to be 6 mg/kg bw/d for males and ca. 33 mg/kg bw/d for females, respectively.
In conclusion the NOEL for carcinogenicity is considered to be 54 mg/kg bw/d for males and ca. 90 mg/kg bw/day for females, respectively.
Rat:
In a carcinogenicity study (LTP, 2003), Oleaflur was administered to Sprague Dawley rats (50 animals/sex/dose) by oral gavage at dose levels of 0, 2.5, 10 or 40 mg/kg bw/day (males) and 0, 15, 45 or 135 (90) mg/kg bw/day (females) for 104 weeks.
The high dose level of the females was decreased from test week 70 onwards for the rest of the study due to a slightly higher than expected body weight reduction in this group compared to the control group. Due to the variable dose concentrations given over the test period the mean value of ca. 120 mg/kg bw/d as high-dose level was calculated).The high dose resulted in an average body weight reduction of 10.9 % in the males and 10.5 % in the females compared to the control group. A slightly higher incidence of ataxia was noted in the high-dosed females (135/90 mg/kg bw) compared to the control. Mortality rates of all dose groups were within the range of the control group.
In conclusion, Oleaflur possessed no carcinogenic potential in the rat tested up to a high dose-level that caused a toxic effect in form of an approx. 10 % weight loss compared to the control.
Therefore the NOEL for systemic toxicity was established to be 10 mg/kg bw/d for males and ca. 45 mg/kg bw/d for females, respectively.
In conclusion the NOEL for carcinogenicity is considered to be 40 mg/kg bw/d for males and ca. 120 mg/kg bw/day for females, respectively.
An additional study confirms the lack of carcinogenic properties of NaF.
To determine the carcinogenic potential of sodium fluoride (NaF), in a two year carcinogenicity study Sprague-Dawley rats (70 per sex per dose) were fed a diet containing NaF for up to 99 weeks. Rats were receiving NaF at a dose of 4,10, or 25 mg/kg per day added to a low-fluoride diet were compared with controls receiving either a low-fluoride diet or laboratory chow.
A 30 % decrease in weight gain occurred at an NaF dose of 25 mg/kg per day. Evidence of fluoride toxicity was seen in the teeth, bones, and stomach, and the incidence and severity of these changes were related to the dose of NaF and the duration of exposure. Despite clear evidence of toxicity (LOEL Systemic toxicity 4 mg/kg bw/d), NaF did not alter the incidence of preneoplastic and neoplastic lesions at any site in rats of either sex. Results from this study indicate that NaF is not carcinogenic in Sprague-Dawley rats. Hence, the NOEL for carcinogenicity is considered to be 25 mg/kg bw/day.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.